Inhibition of DNA Methyltransferase DNMT1 Reverses Th2 Response Polarisation and Alleviates Allergic Rhinitis
Clinical and Experimental Pharmacology and Physiology · 2025
DOI: 10.1111/1440-1681.70015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, 2025. Verfasst von Peng Zou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Otolaryngology Head and Neck Surgery, The First People's Hospital of Kunming, Kunming, China. Hauptthemen laut MEDLINE: DNA (Cytosine-5-)-Methyltransferase 1, Rhinitis, Allergic, Th2 Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Background
Type 2 T helper (Th2) cells‐mediated immune response plays vital roles in allergic rhinitis (AR), and DNA methylation is previously found to be closely related to AR development.
Aims
Our study aims to reveal the detail mechanism of DNA methylation affecting Th2 response in AR.
Methods
Mice were stimulated with ovalbumin (OVA) to induce AR symptoms, and CD4 + T cells were subjected to Th2 induction culture. Real‐time quantitative PCR, western blot, flow cytometry, and enzyme‐linked immunosorbent assay were performed to analyse the activation of Th2 response.
Results
DNA methyltransferase 1 (DNMT1) was significantly upregulated in OVA‐induced AR model mice, and DNMT1 knockdown alleviated AR symptoms and pathological changes of nasal mucosa tissues in the model mice. DNMT1 knockdown obviously reduced the expression of GATA binding protein 3 (GATA3), the ratio of interleukin (IL)‐4 + CD4 + cells and the release of Th2 cytokines, but elevated the expression of T‐box expressed in T cells (T‐bet), the ratio of interferon (IFN)‐γ + CD4 + cells and the levels of Th1 cytokines to improve Th1/Th2 imbalance in the model mice and Th2‐induced CD4 + T cells. Mechanistically, DNMT1 promoted promoter methylation of forkhead box O3 (FOXO3), inhibited FOXO3 expression and activated the nuclear factor kappa‐B (NF‐κB)/GATA3 signalling. FOXO3 overexpression remarkably inactivated the NF‐κB/GATA3 pathway and mitigated Th2 polarisation in DNMT1‐deficient and Th2‐conditined CD4 + T cells, which was reversed by a NF‐κB inhibitor.
Conclusion
Altogether, DNMT1 downregulated FOXO3 expression to activate the NF‐κB/GATA3 pathway and promote Th2 response in AR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Otolaryngology Head and Neck Surgery, The First People's Hospital of Kunming, Kunming, China.
- Ophthalmology Department, The First People's Hospital of Kunming, Kunming, China.
- Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, China.
ORCID-Profile: Jianguo Li
Zitieren
APA
Zou, P., Li, J., Li, J., & Wang, J. (2025). Inhibition of DNA Methyltransferase DNMT1 Reverses Th2 Response Polarisation and Alleviates Allergic Rhinitis. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.70015
Vancouver
Zou P, Li J, Li J, Wang J. Inhibition of DNA Methyltransferase DNMT1 Reverses Th2 Response Polarisation and Alleviates Allergic Rhinitis. Clinical and Experimental Pharmacology and Physiology. 2025. doi:10.1111/1440-1681.70015
BibTeX
@article{Zou2025,
author = {Zou, Peng and Li, Jianguo and Li, Jia and Wang, Jian},
title = {Inhibition of DNA Methyltransferase DNMT1 Reverses Th2 Response Polarisation and Alleviates Allergic Rhinitis},
journal = {Clinical and Experimental Pharmacology and Physiology},
year = {2025},
doi = {10.1111/1440-1681.70015}
}
EUVIMED